The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.

BACKGROUND The pathogenesis of unstable angina is poorly understood, and predicting the prognosis at the time of hospital admission is problematic. Recent evidence suggests that there may be active inflammation, possibly in the coronary arteries, in this syndrome. We therefore studied the prognostic value of measurements of the circulating acute-phase reactants C-reactive protein and serum amyloid A protein, which are sensitive indicators of inflammation. METHODS We measured C-reactive protein, serum amyloid A protein, creatine kinase, and cardiac troponin T in 32 patients with chronic stable angina, 31 patients with severe unstable angina, and 29 patients with acute myocardial infarction. RESULTS At the time of hospital admission, creatine kinase and cardiac troponin T levels were normal in all the patients, but the levels of C-reactive protein and serum amyloid A protein were > or = 0.3 mg per deciliter (exceeding the 90th percentile of the normal distribution) in 4 of the patients with stable angina (13 percent), 20 of the patients with unstable angina (65 percent), and 22 of the patients with acute myocardial infarction (76 percent). The 20 patients with unstable angina who had levels of C-reactive protein and serum amyloid A protein > or = 0.3 mg per deciliter had more ischemic episodes in the hospital than those with levels < 0.3 mg per deciliter (mean [+/- SD] number of episodes per patient, 4.8 +/- 2.5 vs. 1.8 +/- 2.4; P = 0.004); 5 patients subsequently had a myocardial infarction, 2 died, and 12 required immediate coronary revascularization. In contrast, no deaths or myocardial infarction occurred among the 11 patients with levels of C-reactive protein and serum amyloid A protein < 0.3 mg per deciliter, and only 2 of them required coronary revascularization. Among the patients admitted with a diagnosis of acute myocardial infarction, unstable angina preceded infarction in 14 of the 22 patients (64 percent) with levels of C-reactive protein and serum amyloid A protein > or = 0.3 mg per deciliter but in none of the 7 patients with levels < 0.3 mg per deciliter. CONCLUSIONS Elevation of the sensitive acute-phase proteins C-reactive protein and serum amyloid A protein at the time of hospital admission predicts a poor outcome in patients with unstable angina and may reflect an important inflammatory component in the pathogenesis of this condition.

[1]  P. Limburg,et al.  Rapid automated enzyme immunoassay of serum amyloid A. , 1994, Clinical chemistry.

[2]  G. Specchia,et al.  Increased Expression of Neutrophil and Monocyte Adhesion Molecules in Unstable Coronary Artery Disease , 1993, Circulation.

[3]  C. Patrono,et al.  Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty. , 1993, Journal of the American College of Cardiology.

[4]  A. Maseri,et al.  Comparison of Coronary Angiographic Findings in Acute and Chronic First Presentation of Ischemic Heart Disease , 1993, Circulation.

[5]  M. Nieminen,et al.  Chlamydia Pneumoniae‐Specific Circulating Immune Complexes in Patients With Chronic Coronary Heart Disease , 1993, Circulation.

[6]  B. Giusti,et al.  Transient Intermittent Lymphocyte Activation Is Responsible for the Instabilit of Angina , 1992, Circulation.

[7]  H. Katus,et al.  The prognostic value of serum troponin T in unstable angina. , 1992, The New England journal of medicine.

[8]  H. Okamura,et al.  High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor. , 1992, Journal of immunology.

[9]  A. Ford-hutchinson,et al.  Increased Urinary Leukotriene Excretion in Patients With Cardiac Ischemia: In Vivo Evidence for 5‐Lipoxygenase Activation , 1992, Circulation.

[10]  M. Daemen,et al.  Cytomegalovirus nucleic acid distribution within the human vascular tree. , 1991, The American journal of pathology.

[11]  M. Roncaglioni,et al.  Early coronary reperfusion blunts the procoagulant response of plasminogen activator inhibitor-1 and von Willebrand factor in acute myocardial infarction. , 1990, Journal of the American College of Cardiology.

[12]  D. Lipkin,et al.  Dissociation of Platelet Activation and Spontaneous Myocardial Ischemia in Unstable Angina , 1990, Thrombosis and Haemostasis.

[13]  W. Weintraub,et al.  Elevation of C-reactive protein in "active" coronary artery disease. , 1990, The American journal of cardiology.

[14]  L. Bausserman,et al.  Time course of serum amyloid A response in myocardial infarction. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[15]  P. Armstrong,et al.  ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. , 1989, Journal of the American College of Cardiology.

[16]  M. Alessi,et al.  Plasma Plasminogen Activator Inhibitor‐1 in Angina Pectoris: Influence of Plasma Insulin and Acute‐phase Response , 1989, Arteriosclerosis.

[17]  C. Ehnholm,et al.  Serum amyloid A protein, apolipoprotein A-I, and apolipoprotein B during the course of acute myocardial infarction. , 1988, Journal of clinical pathology.

[18]  S. Takebayashi,et al.  Increased subendothelial infiltration of the coronary arteries with monocytes/macrophages in patients with unstable angina. Histological data on 14 autopsied patients. , 1987, Atherosclerosis.

[19]  M. Weisfeldt,et al.  Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina. , 1987, Journal of the American College of Cardiology.

[20]  K. Nademanee,et al.  Prognostic significance of silent myocardial ischemia in patients with unstable angina. , 1987, Journal of the American College of Cardiology.

[21]  D. Steinberg,et al.  Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Marhaug,et al.  Serum amyloid A protein in acute myocardial infarction. , 2009, Acta medica Scandinavica.

[23]  N. Cristal,et al.  Serum amyloid A concentrations during the course of acute ischaemic heart disease. , 1986, Journal of clinical pathology.

[24]  M. Weisfeldt,et al.  Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. , 1986, The New England journal of medicine.

[25]  E. Kreps,et al.  Inflammation of the coronary arteries in patients with unstable angina. , 1986, Texas Heart Institute journal.

[26]  R. Mulcahy,et al.  Natural history and prognosis of unstable angina. , 1985, American heart journal.

[27]  M. Nobuyoshi,et al.  Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. , 1985, Circulation.

[28]  M. Pepys,et al.  Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. , 1983, Advances in immunology.

[29]  A. Maseri,et al.  Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. , 1982, British heart journal.

[30]  M. Pepys,et al.  Solid phase radioimmunoassays for human C-reactive protein. , 1981, Clinica chimica acta; international journal of clinical chemistry.

[31]  R. Mulcahy,et al.  Unstable angina: natural history and determinants of prognosis. , 1981, The American journal of cardiology.

[32]  D. Karp,et al.  Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. , 1978, The Journal of clinical investigation.